Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference

Abstract

Investigators from academia and industry gathered on April 4 and 5, 2013, in Washington DC at the Arrowhead’s 2 Annual Cancer Immunotherapy Conference. Two complementary concepts were discussed: cancer “stem cells” as targets and therapeutic platforms based on stem cells. 

Topics

8 Figures and Tables